Delta Air Lines, Inc. vs Davita Inc — how do they compare? Delta Air Lines, Inc. trades at $85.92 (market cap $56.68B), while Davita Inc trades at $232.01 (market cap $15.12B). The key difference: Delta Air Lines, Inc. is far larger — about 3.7× Davita Inc's market cap, and Delta Air Lines, Inc. pays a 0.9% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DAL | DVA | |
|---|---|---|
Market Cap | $56.68B | $15.12B |
Sector | Industrials | Health |
52-Week High | $93.66 | $235.71 |
52-Week Low | $51.15 | $103.87 |
Enterprise Value | $72.00B | $27.67B |
Dividend Yield | 0.9% | — |
Signals from Pluang's Aura AI — not financial advice
Delta Air Lines (DAL) trades at $86.19, down 1.37% on the day, with a bullish technical outlook supported by strong earnings beats and positive analyst sentiment. The stock shows solid fundamentals with a P/E of 14.29 and net income margin of 5.78%, while recent news highlights premium demand resilience and AI-driven customer satisfaction improvements. Cash flow trends have strengthened, with net cash flow turning positive in 2025 at $1.08 billion.
The outlook remains favorable with an 81.82% analyst buy rating and a $108.27 consensus price target implying 26% upside. Key risks include fuel cost volatility and competitive pressures, but strong institutional support and consistent earnings performance underpin potential for continued growth amid stable travel demand.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke system network, where it gathers and distributes passengers across the globe through key locations such as Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta's sale of frequent flier miles, particularly to American Express, is a major driver of the firm's profits.
Read more on DAL →DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →